202
Participants
Start Date
October 31, 2007
Primary Completion Date
August 31, 2010
Study Completion Date
September 30, 2011
Placebo
Inactive dummy AMG 655 (to maintain blind)
AMG 655
AMG 655 is an investigational, fully human monoclonal agonist antibody that selectively binds to Death Receptor-5 (DR5).
Modified FOLFOX6
Combination treatment comprising oxaliplatin (85 mg/m2), leucovorin (400 mg/m2) and bolus 5-FU (400 mg/m2) and continuous IV 5-FU (2400 mg/m2)\] administered by intravenous infusion once every 14 days (+3 days)
Bevacizumab
Bevacizumab will be administered at a dose of 5 mg/kg by intravenous infusion on day 1 of each 14 day cycle (+3 days).
Research Site, New York
Research Site, The Bronx
Research Site, Hudson
Research Site, Buffalo
Research Site, Harrisburg
Research Site, Pottsville
Research Site, Philadelphia
Research Site, Newark
Research Site, Washington D.C.
Research Site, Baltimore
Research Site, Baltimore
Research Site, Fairfax
Research Site, Richmond
Research Site, Norfolk
Research Site, Winston-Salem
Research Site, Burlington
Research Site, Raleigh
Research Site, Gastonia
Research Site, Asheville
Research Site, Greenville
Research Site, Lawrenceville
Research Site, Atlanta
Research Site, Miami
Research Site, Miami
Research Site, Boca Raton
Research Site, Kissimmee
Research Site, Leesburg
Research Site, Nashville
Research Site, Memphis
Research Site, Louisville
Research Site, Columbus
Research Site, Middletown
Research Site, Cincinnati
Research Site, Indianapolis
Research Site, Saint Joseph
Research Site, Rochester
Research Site, Great Falls
Research Site, Maywood
Research Site, Harvey
Research Site, St Louis
Research Site, Overland Park
Research Site, Hot Springs
Research Site, Richardson
Research Site, Tyler
Research Site, Wichita Falls
Research Site, Austin
Research Site, Denver
Research Site, Ogden
Research Site, Downey
Research Site, San Diego
Research Site, Rancho Mirage
Research Site, Loma Linda
Research Site, Orange
Research Site, Portland
Research Site, Tacoma
Research Site, Vancouver
Research Site, La Jolla
Research Site, Boston
Research Site, Ann Arbor
Research Site, Long Branch
Research Site, Albuquerque
Lead Sponsor
Amgen
INDUSTRY